IN2014MN02418A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN02418A IN2014MN02418A IN2418MUN2014A IN2014MN02418A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A IN 2418MUN2014 A IN2418MUN2014 A IN 2418MUN2014A IN 2014MN02418 A IN2014MN02418 A IN 2014MN02418A
- Authority
- IN
- India
- Prior art keywords
- methods
- breast cancer
- subject
- gene expression
- evaluating
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261650209P | 2012-05-22 | 2012-05-22 | |
US201361753673P | 2013-01-17 | 2013-01-17 | |
PCT/US2013/042157 WO2013177245A2 (en) | 2012-05-22 | 2013-05-22 | Nano46 genes and methods to predict breast cancer outcome |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014MN02418A true IN2014MN02418A (es) | 2015-08-14 |
Family
ID=49624503
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN2418MUN2014 IN2014MN02418A (es) | 2012-05-22 | 2013-05-22 |
Country Status (12)
Country | Link |
---|---|
US (3) | US20130337444A1 (es) |
EP (1) | EP2852689B1 (es) |
JP (1) | JP6325530B2 (es) |
CN (2) | CN104704128A (es) |
AU (1) | AU2013266419B2 (es) |
BR (1) | BR112014029300A2 (es) |
CA (1) | CA2874492C (es) |
ES (1) | ES2763931T3 (es) |
IL (1) | IL235795B (es) |
IN (1) | IN2014MN02418A (es) |
MX (1) | MX369628B (es) |
WO (1) | WO2013177245A2 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2664679B1 (en) | 2008-05-30 | 2017-11-08 | The University of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
WO2012125828A2 (en) | 2011-03-15 | 2012-09-20 | The University Of North Carolina At Chapell Hill | Methods of treating breast cancer with anthracycline therapy |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
AU2012345789B2 (en) | 2011-11-30 | 2018-02-15 | British Columbia Cancer Agency Branch | Methods of treating breast cancer with taxane therapy |
EP2909337B1 (en) | 2012-10-17 | 2019-01-09 | Spatial Transcriptomics AB | Methods and product for optimising localised or spatial detection of gene expression in a tissue sample |
US20160115551A1 (en) * | 2013-05-13 | 2016-04-28 | Nanostring Technologies, Inc. | Methods to predict risk of recurrence in node-positive early breast cancer |
DK3013984T3 (da) | 2013-06-25 | 2023-06-06 | Prognosys Biosciences Inc | Metode til bestemmelse af spatiale mønstre i biologiske targets i en prøve |
JP2016537010A (ja) * | 2013-09-09 | 2016-12-01 | ブリティッシュ コロンビア キャンサー エージェンシー ブランチ | 予後を予測するための方法及びキット、並びに、放射線照射療法を用いた乳癌の治療方法及びキット |
KR20220100098A (ko) | 2014-11-21 | 2022-07-14 | 나노스트링 테크놀로지스, 인크. | 무효소 및 무증폭 시퀀싱 |
WO2016085841A1 (en) * | 2014-11-24 | 2016-06-02 | Nanostring Technologies, Inc. | Methods and apparatuses for gene purification and imaging |
AU2015359479A1 (en) * | 2014-12-09 | 2017-06-15 | King's College London | Breast cancer treatment with taxane therapy |
ES2972835T3 (es) | 2015-04-10 | 2024-06-17 | 10X Genomics Sweden Ab | Análisis multiplex de especímenes biológicos de ácidos nucleicos espacialmente distinguidos |
WO2017014694A1 (en) * | 2015-07-23 | 2017-01-26 | National University Of Singapore | Wbp2 as a co-prognostic factor with her2 for stratification of patients for treatment |
AU2017268257B2 (en) | 2016-05-16 | 2023-09-07 | Bruker Spatial Biology, Inc. | Methods for detecting target nucleic acids in a sample |
US11352667B2 (en) | 2016-06-21 | 2022-06-07 | 10X Genomics, Inc. | Nucleic acid sequencing |
WO2018074865A2 (ko) * | 2016-10-21 | 2018-04-26 | 서울대학교병원 | 유방암 예후 예측용 조성물 및 방법 |
CA3043489A1 (en) | 2016-11-21 | 2018-05-24 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
KR101950717B1 (ko) * | 2016-11-23 | 2019-02-21 | 주식회사 젠큐릭스 | 유방암 환자의 화학치료 유용성 예측 방법 |
WO2018144782A1 (en) * | 2017-02-01 | 2018-08-09 | The Translational Genomics Research Institute | Methods of detecting somatic and germline variants in impure tumors |
EP3668998A1 (en) | 2017-10-06 | 2020-06-24 | Cartana AB | Rna templated ligation |
KR102071491B1 (ko) * | 2017-11-10 | 2020-01-30 | 주식회사 디시젠 | 차세대 염기서열분석을 이용한 기계학습 기반 유방암 예후 예측 방법 및 예측 시스템 |
EP3794146A1 (en) | 2018-05-14 | 2021-03-24 | Nanostring Technologies, Inc. | Chemical compositions and methods of using same |
CN113302313A (zh) * | 2018-11-05 | 2021-08-24 | 拜恩科技诊断有限责任公司 | 乳腺癌的预测方法 |
CA3139791A1 (en) | 2019-05-31 | 2020-12-03 | 10X Genomics, Inc. | Method of detecting target nucleic acid molecules |
JP7352937B2 (ja) * | 2019-07-19 | 2023-09-29 | 公立大学法人福島県立医科大学 | 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット |
EP3945136A1 (en) * | 2020-07-28 | 2022-02-02 | Hospital Clínic de Barcelona | In vitro method for the prognosis of patients suffering from her2-positive breast cancer |
US12060603B2 (en) | 2021-01-19 | 2024-08-13 | 10X Genomics, Inc. | Methods for internally controlled in situ assays using padlock probes |
EP4453259A1 (en) * | 2021-12-20 | 2024-10-30 | Reveal Genomics S.L. | Development and validation of an in vitro method for the prognosis of patients suffering from her2-positive breast cancer |
CN117965734B (zh) * | 2024-02-02 | 2024-09-24 | 奥明星程(杭州)生物科技有限公司 | 一种用于检测硬纤维瘤的基因标志物、试剂盒、检测方法及应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
EP0604552B1 (en) | 1991-09-18 | 1997-02-12 | Affymax Technologies N.V. | Method of synthesizing diverse collections of oligomers |
US5677195A (en) | 1991-11-22 | 1997-10-14 | Affymax Technologies N.V. | Combinatorial strategies for polymer synthesis |
US5384261A (en) | 1991-11-22 | 1995-01-24 | Affymax Technologies N.V. | Very large scale immobilized polymer synthesis using mechanically directed flow paths |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
EP0880598A4 (en) | 1996-01-23 | 2005-02-23 | Affymetrix Inc | RAPID EVALUATION OF NUCLEIC ACID ABUNDANCE DIFFERENCE, WITH A HIGH-DENSITY OLIGONUCLEOTIDE SYSTEM |
JP2001521753A (ja) | 1997-10-31 | 2001-11-13 | アフィメトリックス インコーポレイテッド | 成人臓器及び胎児臓器中の発現プロフィール |
US6020135A (en) | 1998-03-27 | 2000-02-01 | Affymetrix, Inc. | P53-regulated genes |
US6750015B2 (en) * | 2000-06-28 | 2004-06-15 | Kathryn B. Horwitz | Progesterone receptor-regulated gene expression and methods related thereto |
US20020168639A1 (en) * | 2000-09-22 | 2002-11-14 | Muraca Patrick J. | Profile array substrates |
US7056674B2 (en) * | 2003-06-24 | 2006-06-06 | Genomic Health, Inc. | Prediction of likelihood of cancer recurrence |
EP2469439A2 (en) * | 2003-09-29 | 2012-06-27 | Pathwork Diagnostics, Inc. | Systems and methods for detecting biological features |
CA2574447A1 (en) | 2004-07-15 | 2006-01-26 | University Of Utah Research Foundation | Housekeeping genes and methods for identifying the same |
CN101061480A (zh) * | 2004-09-22 | 2007-10-24 | 三路影像公司 | 用来分析和优化用于癌症诊断的标记候选物的方法和计算机程序产品 |
US20090299640A1 (en) | 2005-11-23 | 2009-12-03 | University Of Utah Research Foundation | Methods and Compositions Involving Intrinsic Genes |
AU2006330834B2 (en) | 2005-12-23 | 2013-09-12 | Bruker Spatial Biology, Inc. | Compositions comprising oriented, immobilized macromolecules and methods for their preparation |
EP1963531B1 (en) | 2005-12-23 | 2011-09-21 | Nanostring Technologies, Inc. | Nanoreporters and methods of manufacturing and use thereof |
WO2008124847A2 (en) | 2007-04-10 | 2008-10-16 | Nanostring Technologies, Inc. | Methods and computer systems for identifying target-specific sequences for use in nanoreporters |
WO2008150512A2 (en) * | 2007-06-04 | 2008-12-11 | University Of Louisville Research Foundation, Inc. | Methods for identifying an increased likelihood of recurrence of breast cancer |
ES2618353T3 (es) * | 2007-09-06 | 2017-06-21 | Biotheranostics, Inc. | Clasificación de tumores y pronóstico del cáncer de mama |
EP2664679B1 (en) * | 2008-05-30 | 2017-11-08 | The University of North Carolina At Chapel Hill | Gene expression profiles to predict breast cancer outcomes |
JP5836803B2 (ja) | 2008-08-14 | 2015-12-24 | ナノストリング テクノロジーズ, インコーポレイテッド | 安定したナノレポーター |
UA110790C2 (uk) * | 2010-03-31 | 2016-02-25 | Сівідон Діагностікс Гмбх | Спосіб передбачування рецидиву раку молочної залози при ендокринному лікуванні |
-
2013
- 2013-05-22 IN IN2418MUN2014 patent/IN2014MN02418A/en unknown
- 2013-05-22 JP JP2015514143A patent/JP6325530B2/ja active Active
- 2013-05-22 MX MX2014014275A patent/MX369628B/es active IP Right Grant
- 2013-05-22 CN CN201380038875.4A patent/CN104704128A/zh active Pending
- 2013-05-22 CA CA2874492A patent/CA2874492C/en active Active
- 2013-05-22 EP EP13794236.3A patent/EP2852689B1/en active Active
- 2013-05-22 WO PCT/US2013/042157 patent/WO2013177245A2/en active Application Filing
- 2013-05-22 CN CN201911216650.9A patent/CN111500718A/zh active Pending
- 2013-05-22 US US13/899,656 patent/US20130337444A1/en not_active Abandoned
- 2013-05-22 AU AU2013266419A patent/AU2013266419B2/en active Active
- 2013-05-22 ES ES13794236T patent/ES2763931T3/es active Active
- 2013-05-22 BR BR112014029300A patent/BR112014029300A2/pt not_active Application Discontinuation
-
2014
- 2014-11-20 IL IL235795A patent/IL235795B/en active IP Right Grant
-
2020
- 2020-02-14 US US16/792,051 patent/US20200332368A1/en not_active Abandoned
-
2022
- 2022-09-29 US US17/936,745 patent/US20230272476A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
CN104704128A (zh) | 2015-06-10 |
BR112014029300A2 (pt) | 2017-07-25 |
AU2013266419B2 (en) | 2018-09-27 |
EP2852689B1 (en) | 2019-12-11 |
IL235795B (en) | 2020-02-27 |
AU2013266419A1 (en) | 2014-12-11 |
IL235795A0 (en) | 2015-01-29 |
US20130337444A1 (en) | 2013-12-19 |
EP2852689A4 (en) | 2016-05-11 |
WO2013177245A3 (en) | 2015-01-29 |
US20230272476A1 (en) | 2023-08-31 |
ES2763931T3 (es) | 2020-06-01 |
CA2874492A1 (en) | 2013-11-28 |
JP2015518724A (ja) | 2015-07-06 |
CN111500718A (zh) | 2020-08-07 |
JP6325530B2 (ja) | 2018-05-16 |
CA2874492C (en) | 2021-10-19 |
EP2852689A2 (en) | 2015-04-01 |
WO2013177245A2 (en) | 2013-11-28 |
US20200332368A1 (en) | 2020-10-22 |
MX2014014275A (es) | 2015-07-06 |
MX369628B (es) | 2019-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014MN02418A (es) | ||
CY1114993T1 (el) | Προφιλ εκφρασης γονιδιου για να προβλεπονται εκβασεις καρκινου μαστου | |
MX2019007814A (es) | Algoritmo de perfil de expresion genica y prueba para determinar la prognosis de cancer de prostata. | |
MX2020001156A (es) | Metodo para el pronostico y tratamiento de metastasis de cancer. | |
NZ599194A (en) | Methods to predict clinical outcome of cancer | |
MX2019000091A (es) | Metodo para el pronostico y tratamiento de cancer metastasico de los huesos originado de cancer de mama. | |
WO2010051314A3 (en) | Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations | |
PH12014502410A1 (en) | Breast cancer prognosis, prediction of progesterone receptor subtype and|prediction of response to antiprogestin treatment based on gene expression | |
NZ621638A (en) | Dna methylation in colorectal and breast cancer diagnostic methods | |
WO2011153545A3 (en) | Gene expression signature as a predictor of chemotherapeutic response in breast cancer | |
CY1117838T1 (el) | Παραγοντες προβλεψης για θεραπευτικη αγωγη καρκινου | |
WO2014184679A3 (en) | Method for the prognosis and treatment of renal cell carcinoma metastasis | |
MX2013008252A (es) | Firma de pronostico para la recurrencia de cancer colorrectal. | |
BR112015022977A2 (pt) | métodos para predição de risco de metástase em melanoma cutâneo | |
MX2016012718A (es) | Determinación de polimorfismos de un solo nucleótido útil para predecir la respuesta para rasagilina. | |
WO2014023808A3 (en) | Method for evaluating a cancer patient for propensity to respond to a therapy | |
RU2010149541A (ru) | Способ прогнозирования развития метаболического синдрома у пациента с абдоминальным ожирением | |
Eapen | Relapsed acute lymphoblastic leukemia: Is it crucial to achieve molecular remission prior to transplant? | |
MX2017004816A (es) | Métodos para predecir resultados clínicos en sujetos afectados con colitis ulcerosa. | |
RU2012140862A (ru) | Способ прогнозирования риска возникновения переломов | |
UA108260U (uk) | Спосіб прогнозування розвитку остеопорозу | |
WO2011133500A3 (en) | Detection and analysis of epigenetic and genetic changes in tumor tissue | |
Salmoiraghi et al. | Next Generation Sequencing (NGS) of TP53 Gene Allows to Identify a Very High Risk Group of Philadelphia Negative Acute Lymphoblastic Leukemia (ALL) Patients | |
Brennan | Quantifying Biomarker Risks and Benefits | |
Ellis | Whole Genome Sequencing for Luminal-Type Breast Cancer |